STOCK TITAN

Sol-Gel Technologies (SLGL) CFO details share and option holdings

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Sol-Gel Technologies Ltd. Chief Financial Officer Eyal Ben-Or filed an initial ownership report showing direct holdings of 1,000 Ordinary Shares and several stock option awards. These include options over 7,500 Ordinary Shares at an exercise price of 69.5000 per share, expiring on January 19, 2036. Footnotes state that some options are fully vested, while others vest 25% on specified dates and then in equal quarterly installments over three years, subject to his continued service.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Ben-Or Eyal

(Last)(First)(Middle)
C/O SOL-GEL TECHNOLOGIES LTD.
7 GOLDA MEIR STREET

(Street)
NESS ZIONA7403650

(City)(State)(Zip)

ISRAEL

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026
3. Issuer Name and Ticker or Trading Symbol
Sol-Gel Technologies Ltd. [ SLGL ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares(1)1,000D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy) (2)08/21/2027Ordinary Shares(1)360$55.66D
Stock Option (right to buy) (3)12/16/2029Ordinary Shares(1)180$83.2D
Stock Option (right to buy) (4)03/29/2032Ordinary Shares(1)405$73.8D
Stock Option (right to buy) (5)07/11/2034Ordinary Shares(1)2,500$8.342D
Stock Option (right to buy) (6)02/18/2035Ordinary Shares(1)4,055$8.96D
Stock Option (right to buy) (7)01/19/2036Ordinary Shares(1)7,500$69.5D
Explanation of Responses:
1. Ordinary shares, NIS 1.00 par value per share.
2. The option is fully vested.
3. The option is fully vested.
4. The option vested as to 25% of the Ordinary Shares on March 29, 2023 and vests as to the remainder of the Ordinary Shares in equal quarterly installments over the following three years, subject to the Reporting Person's continued service through such dates.
5. The option vested as to 25% of the Ordinary Shares on July 11, 2025 and vests as to the remainder of the Ordinary Shares in equal quarterly installments over the following three years, subject to the Reporting Person's continued service through such dates.
6. The option vested as to 25% of the Ordinary Shares on February 18, 2026 and vests as to the remainder of the Ordinary Shares in equal quarterly installments over the following three years, subject to the Reporting Person's continued service through such dates.
7. The option will vest as to 25% of the Ordinary Shares on January 19, 2027 and vests as to the remainder of the Ordinary Shares in equal quarterly installments over the following three years, subject to the Reporting Person's continued service through such dates.
Remarks:
Exhibit 24 - Power of Attorney
/s/ Eyal Ben-Or03/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Sol-Gel Technologies (SLGL) Form 3 filing show for CFO Eyal Ben-Or?

The Form 3 shows CFO Eyal Ben-Or’s initial holdings in Sol-Gel Technologies, including 1,000 Ordinary Shares held directly and multiple stock option awards over additional Ordinary Shares with specified exercise prices and expiration dates, plus detailed vesting schedules linked to his continued service.

How many Sol-Gel Technologies (SLGL) shares does the CFO own directly?

CFO Eyal Ben-Or directly owns 1,000 Ordinary Shares of Sol-Gel Technologies. This direct ownership is reported separately from his stock options, which, if exercised, would allow him to acquire additional Ordinary Shares at preset exercise prices before their respective expiration dates.

What stock options are reported for the Sol-Gel Technologies (SLGL) CFO in the Form 3?

The filing lists several stock option awards to acquire Ordinary Shares at exercise prices such as 8.3420, 8.9600, 55.6600, 73.8000, 83.2000, and 69.5000 per share, with expiration dates ranging from August 21, 2027 to January 19, 2036.

How do the Sol-Gel Technologies (SLGL) CFO’s stock options vest according to the Form 3 footnotes?

Some options are already fully vested, while others vest 25% on specific initial dates, then in equal quarterly installments over three years. Vesting is conditioned on Eyal Ben-Or’s continued service with Sol-Gel Technologies through each scheduled vesting date, as described in the footnotes.

Did the Sol-Gel Technologies (SLGL) CFO buy or sell shares in this Form 3?

The Form 3 primarily reports existing holdings and option positions for CFO Eyal Ben-Or, not new purchases or sales. Transaction summaries classify the entries as holdings with unknown transaction codes, and there are no recorded buy or sell transactions in this dataset.

What is the largest single stock option position reported for the Sol-Gel Technologies (SLGL) CFO?

The largest single option position covers 7,500 underlying Ordinary Shares at an exercise price of 69.5000 per share, expiring on January 19, 2036. This option will vest 25% on January 19, 2027 and then in equal quarterly installments over three years.
Sol Gel Technolg

NASDAQ:SLGL

View SLGL Stock Overview

SLGL Rankings

SLGL Latest News

SLGL Latest SEC Filings

SLGL Stock Data

211.83M
835.67k
Biotechnology
Healthcare
Link
Israel
Ness Ziona